FDA Medication Guide: Update

US Food and Drug Administration

The FDA Medication Guides page has been (updated) http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm

The following are updated or newly added:

• YERVOY (ipilimumab), Bristol-Myers Squibb Company
• XARTEMIS XR (oxycodone hydrochloride and acetaminophen) Extended-Release Tablets, CII
• VIIBRYD (vilazodone hydrochloride) Tablets, Actavis, Inc.
• SIGNIFOR [sig-na-for] (pasireotide) Injection,
• FARXIGA (dapagliflozin) tablets, Astra Zeneca Pharmaceuticals LP
• DUETACT (pioglitazone and glimepiride) tablets, Takeda Pharmaceuticals America, Inc.
• CIPRO (ciprofloxacin hydrochloride) Tablets for oral use, CIPRO® (ciprofloxacin hydrochloride) for oral suspension; CIPRO® XR (ciprofloxacin hydrochloride) Tablets, for oral use, CIPRO® IV (ciprofloxacin) Injection for intravenous infusion, Bayer HealthCare Pharmaceuticals Inc.
• BONIVA (ibandronate), Genentech, Inc.
• AVANDARYL (rosiglitazone maleate and glimepiride) tablets, GlaxoSmithKline

Learn about FDA

Global Compliance Seminar (GCS) provides global and FDA regulatory consulting and training services to the FDA-regulated industry in collaboration with the Regulatory Doctor. The US FDA is an Agency under the US Department of Health and Human Services (DHHS).